The Methanol Extract of Azadirachta indica A. Juss Leaf Protects Mice Against Lethal Endotoxemia and Sepsis

被引:10
作者
Kim, Woong-Hyun [2 ]
Song, Hyun-Ok [2 ]
Jin, Chun Mei [2 ]
Hur, Jong Moon [3 ]
Lee, Hwa Sung [3 ]
Jin, Han Yong [2 ]
Kim, Sung Yeon [1 ]
Park, Hyun [2 ]
机构
[1] Wonkwang Univ, Coll Pharm, Inst Pharmaceut Res & Dev, Iksan 570749, South Korea
[2] Wonkwang Univ, Sch Med, Zoonosis Res Ctr, Dept Infect Biol, Iksan 570749, South Korea
[3] Globalherb Co Ltd, Inst Oriental Med Sci, Andong 760801, South Korea
基金
新加坡国家研究基金会;
关键词
Sepsis; Azadirachta indica A. Juss; Rutin; NO; TNF-alpha; LPS; TUMOR-NECROSIS-FACTOR; NITRIC-OXIDE; SHOCK; TRANSCRIPTION; ACTIVATION; FLAVONOIDS; RESPONSES; CYTOKINE;
D O I
10.4062/biomolther.2012.20.1.096
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the present study, the inhibitory effect of neem leaf extract (NLE) on lipopolysaccaride (LPS)-induced nitric oxide (NO) and tumor necrosis factor-alpha (TNF-alpha) production was examined both in vitro and in vivo. In vitro study revealed that NLE treatment (100 mu g/ml) inhibits LPS (100 ng/ml)-induced NO production by 96% and TNF-alpha production by 32%. The reduction in NO production is probably conferred by the complete suppression of inducible nitric oxide synthase (iNOS) expression. Interestingly, in vivo NLE significantly improved the survival rate of mice in an experimental sepsis model. Administration of NLE (100 mg/kg) 24 h before LPS treatment (20 mg/kg) improved the survival rate of mice by 60%. The inhibition of plasma NO and TNF-alpha production by NLE is likely to account for the improved survival of mice. Our results suggest that NLE may present a promising avenue in the development of therapeutic agents for the treatment of inflammatory diseases.
引用
收藏
页码:96 / 103
页数:8
相关论文
共 33 条
  • [1] Almas K, 1999, INDIAN J DENT RES, V10, P3
  • [2] Septic shock
    Annane, D
    Bellissant, E
    Cavaillon, JM
    [J]. LANCET, 2005, 365 (9453) : 63 - 78
  • [3] Immune depression in polymicrobial sepsis: The role of necrotic (injured) tissue and endotoxin
    Ayala, A
    Song, GY
    Chung, CS
    Redmond, KM
    Chaudry, IH
    [J]. CRITICAL CARE MEDICINE, 2000, 28 (08) : 2949 - 2955
  • [4] Badam Lalita, 1999, Journal of Communicable Diseases, V31, P79
  • [5] Efficacy and safety of recombinant human activated protein C for severe sepsis.
    Bernard, GR
    Vincent, JL
    Laterre, P
    LaRosa, SP
    Dhainaut, JF
    Lopez-Rodriguez, A
    Steingrub, JS
    Garber, GE
    Helterbrand, JD
    Ely, EW
    Fisher, CJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) : 699 - 709
  • [6] Tumor necrosis factor-α-induced caspase activation mediates endotoxin-related cardiac dysfunction
    Carlson, DL
    Willis, MS
    White, J
    Horton, JW
    Giroir, BP
    [J]. CRITICAL CARE MEDICINE, 2005, 33 (05) : 1021 - 1028
  • [7] Inhibition of TPA-induced protein kinase C and transcription activator protein-1 binding activities by theaflavin-3,3′-digallate from black tea in NIH3T3 cells
    Chen, YC
    Liang, YC
    Lin-Shiau, SY
    Ho, CT
    Lin, JK
    [J]. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 1999, 47 (04) : 1416 - 1421
  • [8] Small Molecules in Treatment of Sepsis
    Hu, Yan
    Xie, Guo Hao
    Chen, Qi Xing
    Fang, Xiang Ming
    [J]. CURRENT DRUG TARGETS, 2011, 12 (02) : 256 - 262
  • [9] Benzoxathiole derivative blocks lipopolysaccharide-induced nuclear factor-κB activation and nuclear factor-κB-regulated gene transcription through inactivating inhibitory κB kinase β
    Kim, Byung Hak
    Roh, Eunmiri
    Lee, Hwa Young
    Lee, In-Jeong
    Ahn, Byeongwoo
    Jung, Sang-Hun
    Lee, Heesoon
    Han, Sang-Bae
    Kim, Youngsoo
    [J]. MOLECULAR PHARMACOLOGY, 2008, 73 (04) : 1309 - 1318
  • [10] Regulation of lipopolysaccharide-induced inducible nitric-oxide synthase expression through the nuclear factor-κB pathway and interferon-β/tyrosine kinase 2/Janus tyrosine kinase 2-signal transducer and activator of transcription-1 signaling cascades by 2-naphthylethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (THI 53), a new synthetic isoquinoline alkaloid
    Kim, Hye Jung
    Tsoyi, Konstantin
    Heo, Ja Myung
    Kang, Young Jin
    Park, Min Kyu
    Lee, Young Soo
    Lee, Jae Heun
    Seo, Han Geuk
    Yun-Choi, Hye Sook
    Chang, Ki Churl
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2007, 320 (02) : 782 - 789